A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study’ (Int J Surg 2023; 109:1299–310)

aDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan bSchool of Medicine cInstitute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan dDivision of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan eDivision of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan T.-I. Huo and S.-Y. Ho contributed equally to this study. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Published online ■ ■ *Corresponding author. Address: Professor of Medicine, Department of Medical Research, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Taipei 11217, Taiwan, Tel: + 886 2 2871 2121 Ext.: 7434, Fax: + 886 2 2873 9318. E-mail address: [email protected] (T.-I. Huo). This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/